Delivery Order SPE2DB22D1202-SPE2DB24FVHF7
Award Date
7/18/24
Potential Completion Date
8/8/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ZILRETTA 32 MG VIALS. The $4,206.84 firm fixed-price contract has an ultimate completion date of November 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ZILRETTA 32 MG VIALS. The contract has a ceiling value of $1,402.28 and a completion date of December 4, 2024. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,714.90 firm fixed-price delivery order is for the supply of ZILRETTA 32 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is for the supply of ZILRETTA 32 MG VIALS, a specialty medication, valued at $1,485.96. The contract has a period of performance through February 27, 2025 and is a firm fixed-price delivery order. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $8,413.68, is for the delivery of ZILRETTA 32 MG VIALS. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary contract...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. The contract is for the provision of ZILRETTA 32 MG VIALS, a pharmaceutical product. The contract has a ceiling value of $1,752.85 and a period of performance ending on June 13, 2024. Amerisourcebergen, a large pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZILRETTA 32 MG VIALS, a medical product, with a firm fixed price of $5,572.35 and a period of performance through February 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,088.07 firm fixed price delivery order is for 4,566,639,793 units of ZILRETTA 32 MG VIALS. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, for the supply of ZILRETTA 32 MG VIALS. The award, valued at $1,752.85, is a firm fixed-price contract with a completion date of May 29, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The...
Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $3,505.70 by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of ZILRETTA 32 MG VIALS with a completion date of March 14, 2024. This award is not associated with any set-aside designation. The contract is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract...